HMC showcases innovation in cardiac surgery at WISH 2015
At the World Innovation Summit for Health (WISH) being held at the Qatar National Convention Centre, Hamad Medical Corporation (HMC) showcased its latest innovation in cardiac surgery – the Q Stent.
The Q Stent project was started by a doctor at Heart Hospital looking for a solution to a problem that occurs in prolonged cardiac surgeries, where the heart expands and it is not possible to close the patient’s chest immediately. The Q Stent acts as a stable sterile device to hold or prop the patient’s chest open, thereby maximizing patient safety. It is expected to replace the currently used, hand-crafted, suboptimal solutions for stenting the sternum for delayed closure.
Q Stent’s ergonomic design provides firm stenting of the sternum, with provision of maximum space for accommodating the swollen heart. Its solid block fabrication, without any moving parts, would decrease the risks of injuries and infection after such procedures.
Dr. Rashid Mazhar, Consultant in Cardiothoracic Surgery at Heart Hospital said the most common use for the device would be in pediatric heart surgery.
“Children have much smaller rib cages and therefore the problem of their heart swelling after a long surgical procedure is more prevalent,” he explained. We have made Q Stents in several sizes so that they are suitable in pediatric and adult surgeries. I feel strongly that the Q Stent will help many cardiac surgeons in the future.”
The Q Stent project is being supported by the HMC Office for the Academic Health System who recently engaged a local firm to file for the patent for this important innovation.